If you’re a diabetic, you’ve likely been hit by President Joe Biden’s reversal of a rule signed by President Trump in December aimed at lowering prescription prices for insulin and adrenaline.
The Department of Health and Human Services (HHS) announced Thursday that the rule will be put on hold until it can be reviewed over the next 60 days.
Insulin is used to treat diabetes. Around 20 million Americans suffer from it. Adrenaline is used to treat severe allergic reactions.
Bloomberg Law reported that the freeze is the Biden administration’s large-scale effort to review all of the Trump administration’s health policies. If there is a “factual, legal, or policy concern”, HHS will delay the rules and consult the Bureau of Administration and Budget for other action.
It was a move that put Mary Vought, executive director of the Senate Conservatives, into question whether Democrats want higher insulin prices.
Announcing Biden’s order on Twitter, she wrote, “Biden reversed Trump’s executive order to lower insulin and adrenaline prices. Democrats want insulin prices higher?”
Biden canceled Trump’s executive order to lower insulin and adrenaline prices.
Democrats want higher insulin prices? pic.twitter.com/w85pkIAchG
– Mary Vought (@MaryVought) January 22, 2021
Last December, Trump ordered community health centers to help low-income patients buy insulin and adrenaline. It was an effort to make drug costs more affordable. Due to Biden’s reversal, the rule will now not be implemented until March 22nd if approved by the new administration.
It’s no secret that Big Pharma hated President Trump in his efforts to cut drug prices and kept an election promise he kept during his tenure. Trump’s “Most Favored Nation Act” even aimed to lower Medicare prices by linking the cost of certain drugs to cheaper prices in other developed countries. According to humanevents.com, Biden’s move has made Big Pharma like Joe Biden – especially now.
The Sovereign Wealth Fund Institute reports that there are three companies that dominate more than 90% of the global insulin market by value. Eli Lilly and Company, Novo Nordisk A / S and Sanofi SA will benefit from Biden’s freeze.
Humanevents.com also noted that Eli Lilly donated more than $ 138,000 to the Biden campaign during the 2020 election and suggested that “maybe he is just returning the favor”.
US Rep Dan Crenshaw (R-TX) also questioned Biden’s reversal to get rid of all of Trump.
“Why add this to the chopping block? ‘Own’ Trump?” The congressman wrote on Twitter. “Why exactly does Biden NOT want to pass on cost savings on insulin? Diabetics make better money.”
Why add this to the chopping block? “Own” Trump?
Why exactly does Biden NOT want to pass on cost savings on insulin? Diabetics deserve better. https://t.co/daNX64Dtny
– Rep. Dan Crenshaw (@RepDanCrenshaw) January 23, 2021
US Representative Michael Burgess (R-TX), who is also a doctor, tweeted his disappointment with the move of the Biden government, writing:
“Insulin and EpiPens are not new. They have been saving lives for decades. Disappointed with the Biden administration for delaying savings for families and patients dependent on these drugs.”
Insulin and Epipene are not new. You’ve been saving lives for decades. Disappointed with the Biden Administration because of the delay in saving the families and patients who are dependent on these drugs.
– Michael Burgess, MD (@michaelcburgess) January 22, 2021
Stay up to date with the free CBN NEWS APP
Click here to get the app with special notifications on breaking news and top stories